Ventricular arrhythmias in ischemic heart disease: mechanism, prevalence, significance, and management.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001146:Arrhythmia, Sinus / Q000209:etiology; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D001281:Atrial Fibrillation / Q000209:etiology; D001282:Atrial Flutter / Q000209:etiology; D001283:Atrioventricular Node / Q000503:physiopathology; D001919:Bradycardia / Q000209:etiology; D002037:Bundle-Branch Block / Q000209:etiology; D002642:Chick Embryo; D003327:Coronary Disease / Q000150:complications*; D003645:Death, Sudden; D004562:Electrocardiography; D005080:Exercise Test; D006327:Heart Block / Q000209:etiology; D006329:Heart Conduction System / Q000503:physiopathology; D006352:Heart Ventricles; D006760:Hospitalization; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications; D011379:Prognosis; D013610:Tachycardia / Q000209:etiology; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000209:etiology
D000889:Anti-Arrhythmia Agents